Lumos Diagnostics Holdings Ltd.

Lumos Diagnostics Holdings Ltd.

0.06
USD
+0.01
(+20.00%)
-0.01EPS
75.55MMarket Cap
Mar 04Next Earn

Total Valuation

USD

As of June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD carries a market capitalization of 75.55M, placing it among publicly traded companies globally. Its enterprise value stands at 66.06M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap75.55M
Enterprise Value66.06M

Important Dates

LUMOS DIAGNOSTICS HLDGS LTD's next confirmed earnings release is scheduled for March 4, 2027.

Earnings Date3/4/2027

Share Statistics

As of June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD has 944.39M shares outstanding.

Shares Outstanding944.39M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 4.93, and the price-to-book ratio stands at 3.30.

PS Ratio4.93
PB Ratio3.30
P/TBV Ratio8.06

Enterprise Valuation

These figures are as of June 30, 2026. The EV/Sales ratio of 5.01 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 66.06M versus a market cap of 75.55M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales5.01

Financial Position

As of June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD maintains a current ratio of 1.52, meaning it holds 1.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 25.98, indicating elevated leverage, while an interest coverage ratio of -3.38 demonstrates limited ability to service its debt obligations.

Current Ratio1.52
Quick Ratio1.25
Debt / Equity25.98
Debt / EBITDA-1.13
Interest Coverage-3.38

Financial Efficiency

Over the twelve months ended June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD posted a negative return on equity (ROE) of -34.13, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -16.09, reflecting losses generated across the asset base. Inventory turnover of 4.87 indicates how many times LUMOS DIAGNOSTICS HLDGS LTD sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-34.13
Return on Assets (ROA)-16.09
Inventory Turnover4.87

Stock Price Statistics

USD

As of the close on November 16, 2026, LUMOS DIAGNOSTICS HLDGS LTD's stock has declined approximately 64.77% over the past 52 weeks. The 50-day moving average sits at 0.07, while the 200-day moving average is 0.13.

52-Week Price Change-64.77%
50-Day Moving Average0.07
200-Day Moving Average0.13

Income Statement

USD

Over the twelve months ended June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD generated 13.19M in revenue and converted that into -4.95M in net income, yielding earnings per share of -0.01. EBITDA reached -5.27M, while operating income came in at -14.07M.

Revenue13.19M
Gross Profit7.93M
Operating Income-14.07M
Pretax Income-4.95M
Net Income-4.95M
EBITDA-5.27M
EBIT-7.81M
Earnings Per Share (EPS)-0.01

Balance Sheet

USD

As of June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD holds 15.43M in cash and equivalents against 5.94M in total debt, resulting in a net debt position of -15.43M. Total book value stands at 22.86M, with working capital of 6.79M providing operational flexibility.

Cash & Cash Equivalents15.43M
Total Debt5.94M
Net Debt-15.43M
Equity (Book Value)22.86M
Book Value Per Share0.02
Working Capital6.79M

Cash Flow

USD

These figures cover the twelve months ended June 30, 2026.

Capital Expenditures-2.54M

Margins

Over the twelve months ended June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD posted a gross margin of 60.12, reflecting its pricing power and cost economics. The operating margin of -106.69 and net profit margin of -37.54 provide insight into operational efficiency.

Gross Margin60.12
Operating Margin-106.69
Pretax Margin-37.54
Profit Margin-37.54
EBITDA Margin-39.92

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Total shareholder yield is negative at -20.16, meaning LUMOS DIAGNOSTICS HLDGS LTD raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-20.16

Stock Splits

LUMOS DIAGNOSTICS HLDGS LTD's most recent stock split took place on September 6, 2024.

Last Split Date9/6/2024

Scores

As of June 30, 2026, LUMOS DIAGNOSTICS HLDGS LTD has an Altman Z-Score of -3.66, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-3.66